AbbVie
ABBV
$155.30
Share price
1.06%
Change (1 day)
-1.97%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Earnings for AbbVie (ABBV)
Earnings in 2022 (TTM): $13.47 B
According to AbbVie's latest financial reports the company's current earnings (TTM) are $13.47 B. In 2021 the company made an earning of $12.98 B an increase over its 2020 earnings that were of $3.39 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for AbbVie from 2011 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | $13.47 B | 3.76% |
| 2021 | $12.98 B | 282.25% |
| 2020 | $3.39 B | -59.67% |
| 2019 | $8.42 B | 62.13% |
| 2018 | $5.19 B | -32.74% |
| 2017 | $7.72 B | -1.99% |
| 2016 | $7.88 B | 18.65% |
| 2015 | $6.64 B | 180.5% |
| 2014 | $2.36 B | -55.57% |
| 2013 | $5.33 B | -6.86% |
| 2012 | $5.72 B | 56.05% |
| 2011 | $3.66 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $35.96 B | 166.88% | 🇺🇸 USA |
 Eli Lilly LLY | $6.80 B | -49.50% | 🇺🇸 USA |
 Amgen AMGN | $7.34 B | -45.49% | 🇺🇸 USA |
 Biogen BIIB | $3.59 B | -73.35% | 🇺🇸 USA |
 Gilead Sciences GILD | $5.81 B | -56.86% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $7.71 B | -42.77% | 🇺🇸 USA |
 AstraZeneca AZN | $3.83 B | -71.58% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $7.60 B | -43.60% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | $0.22 B | -98.36% | 🇺🇸 USA |